Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (8)
  • 2024 (10)
  • 2023 (7)
  • 2022 (9)

Subject

  • Drug Trafficking (1007)
  • OCDETF/Task Force (386)
  • Guns/Weapons (282)
  • Fake Pills (107)
  • Gangs (39)
  • Money Laundering (32)
  • HIDTA (26)
  • Prescription Drugs (24)
  • Arrests/Convictions - Major (13)
  • Guilty Plea (9)
  • Task Forces/Task Force Officers (9)
  • Counterfeit Pills (8)
  • Pharmaceuticals/Pharmacists/Physicians (5)
  • Major Law Enforcement Operation (4)
  • Outreach/Drug Prevention (3)
  • Overdose (3)
  • Take Back Day (3)
  • Fentanyl Awareness (2)
  • One Pill Can Kill (2)
  • Synthetic drugs (2)
  • Press Conferences (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)
  • Red Ribbon (1)
  • Diversion Division (35)

Drug Name

  • Fentanyl (10)
  • Hydromorphone (4)
  • Opioids (4)
  • Benzodiazepines (3)
  • Oxycodone (2)
  • Amphetamines (1)
  • Cocaine (1)
  • Heroin (1)
  • Methamphetamine (1)
  • Morphine (1)

Field Division

  • Washington, DC (34)
  • Seattle (25)
  • New York (23)
  • Chicago (18)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (10)
  • Sede (10)
  • New Orleans (8)
  • El Paso (7)
  • San Francisco (7)
  • St. Louis (7)
  • Dallas (5)
  • Rocky Mountain (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
  • New England (35)
Clear All Results
35 Results - Showing 21 to 30
PRESS RELEASE

Former Nurse Sentenced for Drug Diversion from Boston-Area Hospital

BOSTON – A former nurse was sentenced yesterday in federal court today in Boston for diverting opioids from a Boston-area hospital. Andrea Falzano, 39, of Winchester, was sentenced by U.S. District Court Judge Nathaniel M. Gorton to three months in prison and one year of supervised release. In August 2023...
PRESS RELEASE

New Hampshire Doctor Indicted for Unlawfully Distributing Opioids and Benzodiazepines

CONCORD, N.H. – A doctor practicing in the north country of New Hampshire was indicted in connection with his unlawful distribution of opioids and benzodiazepines, U.S. Attorney Jane E. Young announces. Robert G. Soucy Jr., D.O., 70, of Columbia, New Hampshire, was indicted on 12 counts of distribution of controlled...
PRESS RELEASE

Health Care Company and Cheshire Pharmacy Pay $500K to Resolve Controlled Substances Act Allegations

CHESHIRE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, announced that Clarest, LLC, doing business as Clarest Health, ProCare LTC New England LTC, and ProCare LTC Pharmacy of Connecticut LLC...
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
PRESS RELEASE

Cheshire Medical Center to Pay $2 Million to Settle Allegations of Controlled Substances Act Violations

CONCORD, N.H. – U.S. Attorney Jane E. Young announces today that Cheshire Medical Center (CMC) in Keene will pay $2 million to resolve allegations that it violated the Controlled Substances Act (CSA) by failing to keep accurate records of controlled substances, including opioids. “Cheshire Medical Center’s failure to fulfill its...
PRESS RELEASE

Former Nurse Indicted for Drug Diversion from Boston Hospital

BOSTON – A former nurse has been indicted by a federal grand jury in Boston for allegedly diverting opioids from a Boston-area hospital. Andrea Falzano, 38, of Winchester, was indicted on three counts of unlawfully obtaining controlled substances by fraud, deception and subterfuge. Falzano was arrested this morning and will...
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
PRESS RELEASE

Yale Agrees To Pay $308K To Resolve Allegations Of Violations Of Controlled Substances Act

ORANGE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that Yale University, on behalf of Yale Medicine and the Yale Fertility Center, has entered into a civil settlement agreement with the federal government in which it will pay a total of $308,250 to...
PRESS RELEASE

Nurse Sentenced To Prison For Tampering With Fentanyl Vials

MADISON, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, announced that BRYAN WILSON, 40, of Madison, was sentenced today by U.S. District Judge Michael P. Shea in Hartford to 24 months of imprisonment, followed by three years of supervised release, for tampering with fentanyl vials...
PRESS RELEASE

Dedham Veterinarian Agrees To Pay $15,000 Settlement To Resolve Allegations Of Inadequate Recordkeeping Of Controlled Substances

BOSTON – A Dedham veterinarian has agreed to resolve allegations that he maintained inadequate records of controlled substances, improperly stored controlled substances at his office and residence, ordered controlled substances without a Drug Enforcement Administration (DEA) registration, and failed to report he was on probation on his DEA registration forms...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster